Universidad del Desarrollo

Now showing 1 - 9 of 9

Some of the metrics are blocked by your
consent settings
Methodology of the joint malaria prevention recommendations of Switzerland, Germany, Belgium and The Netherlands
(2024)
Olivia Veit
;
Ula Maniewski-Kelner
;
Camilla Rothe
;
Gilles Eperon
;
Margarita Boering
<jats:p>The expert committees for travel medicine of Belgium, Germany, The Netherlands and Switzerland endorse joint malaria prevention recommendations for travellers. Here, the methodological approach underlying these recommendations, including evidence sources used, risk category definitions and the role of expert opinion, is outlined.</jats:p>
Scopus© Citations 2
Some of the metrics are blocked by your
consent settings
Recommendations for the management of candidemia in children in Latin America
(2013)
María E. Santolaya
;
Flavio de Queiroz Telles
;
Tito Alvarado Matute
;
Arnaldo Lopes Colombo
;
Jeannete Zurita
6Scopus© Citations 13
Some of the metrics are blocked by your
consent settings
Recommendations for the management of candidemia in neonates in Latin America
(2013)
María E. Santolaya
;
Tito Alvarado Matute
;
Flavio de Queiroz Telles
;
Arnaldo Lopes Colombo
;
Jeannete Zurita
18Scopus© Citations 25
Some of the metrics are blocked by your
consent settings
Recommendations for the diagnosis of candidemia in Latin America
(2013)
Arnaldo Lopes Colombo
;
Jorge Alberto Cortes
;
Jeannete Zurita
;
Manuel Guzman-Blanco
;
Tito Alvarado Matute
3Scopus© Citations 17
Some of the metrics are blocked by your
consent settings
Recomendaciones para el manejo de la candidemia en adultos en América Latina
(2013)
Marcio Nucci
;
THOMPSON MOYA, LUIS ADALBERTO
;
Manuel Guzman-Blanco
;
Iris Nora Tiraboschi
;
Jorge Alberto Cortes
Scopus© Citations 37 1
Some of the metrics are blocked by your
consent settings
Validation of Picture Free and Cued Selective Reminding Test for Illiteracy in Lima, Peru
(2022)
Rosa Montesinos
;
Jose F. Parodi
;
Monica M. Diaz
;
Eder Herrera-Perez
;
Elizabeth Valeriano-Lorenzo
<jats:p> Dementia in Latin America is a crucial public health problem. Identifying brief cognitive screening (BCS) tools for the primary care setting is crucial, particularly for illiterate individuals. We evaluated tool performance characteristics and validated the free and total recall sections of the Free and Cued Selective Reminding Test-Picture version (FCSRT-Picture) to discriminate between 63 patients with early Alzheimer’s disease dementia (ADD), 60 amnestic mild cognitive impairment (aMCI) and 64 cognitively healthy Peruvian individuals with illiteracy from an urban area. Clinical, functional, and cognitive assessments were performed. FCSRT-Picture performance was assessed using receiver operating characteristic curve analyses. The mean ± standard deviation scores were 7.7 ± 1.0 in ADD, 11.8 ± 1.6 in aMCI, and 29.5 ± 1.8 in controls. The FCSRT-Picture had better performance characteristics for distinguishing controls from aMCI compared with several other BCS tools, but similar characteristics between controls and early ADD. The FCSRT-Picture is a reliable BCS tool for illiteracy in Peru. </jats:p>
Scopus© Citations 4 1
Some of the metrics are blocked by your
consent settings
Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines
(2015)
Andrea Schilling
;
Mercedes Macias Parra
;
Maricruz Gutierrez
;
Jaime Restrepo
;
Santiago Ucros
<jats:sec> <jats:title>BACKGROUND:</jats:title> <jats:p>This study in 11- to 15-year-old boys and girls compared the immunogenicity and safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] vaccine) administered either concomitantly or nonconcomitantly with 2 vaccines routinely administered in this age group (Menactra [MCV4; Neisseria meningitidis serotypes A/C/Y/W-135] or Adacel [Tdap; diphtheria/tetanus/acellular pertussis]).</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS:</jats:title> <jats:p>Participants received 9vHPV vaccine at day 1 and months 2 and 6; the concomitant group (n = 621) received MCV4/Tdap concomitantly with 9vHPV vaccine at day 1; the nonconcomitant group (n = 620) received MCV4/Tdap at month 1. Antibodies to HPV-, MCV4-, and Tdap-relevant antigens were determined. Injection-site and systemic adverse events (AEs) were monitored for 15 days after any vaccination; serious AEs were monitored throughout the study.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS:</jats:title> <jats:p>The geometric mean titers for all HPV types in 9vHPV vaccine 4 weeks after dose 3, proportion of subjects with a fourfold rise or greater in titers for 4 N meningitidis serotypes 4 weeks after injection with MCV4, proportion of subjects with antibody titers to diphtheria and tetanus ≥0.1 IU/mL, and geometric mean titers for pertussis antigens 4 weeks after injection with Tdap were all noninferior in the concomitant group compared with the nonconcomitant group. Injection-site swelling occurred more frequently in the concomitant group. There were no vaccine-related serious AEs.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS:</jats:title> <jats:p>Concomitant administration of 9vHPV vaccine with MCV4/Tdap was generally well tolerated and did not interfere with the antibody response to any of these vaccines. This strategy would minimize the number of visits required to deliver each vaccine individually.</jats:p> </jats:sec>
Scopus© Citations 54 1 3
Some of the metrics are blocked by your
consent settings
A prospective, multi-center study of Candida bloodstream infections in Chile
(2019)
Maria E. Santolaya
;
THOMPSON MOYA, LUIS ADALBERTO
;
Dona Benadof
;
Cecilia Tapia
;
Claudia Cortés
1Scopus© Citations 37 10
Some of the metrics are blocked by your
consent settings
Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
(2018)
Mehmet Altan
;
Kelley M. Kidwell
;
Vasiliki Pelekanou
;
CARVAJAL HAUSDORF, DANIEL EDUARDO
;
Kurt A. Schalper
Scopus© Citations 43 1

CRIS

Browse

Filters

Settings

Sort By

Results per page

Search Results